- Home
- RRGB vs CRVO Comparison
RRGB vs CRVO Comparison
Compare RRGB & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RRGB
- CRVO
- Stock Information
- Founded
- RRGB 1969
- CRVO 2001
- Country
- RRGB United States
- CRVO United States
- Employees
- RRGB N/A
- CRVO N/A
- Industry
- RRGB Restaurants
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- RRGB Consumer Discretionary
- CRVO Health Care
- Exchange
- RRGB Nasdaq
- CRVO Nasdaq
- Market Cap
- RRGB 93.6M
- CRVO 98.3M
- IPO Year
- RRGB 2002
- CRVO N/A
- Fundamental
- Price
- RRGB $5.18
- CRVO $1.94
- Analyst Decision
- RRGB Strong Buy
- CRVO Buy
- Analyst Count
- RRGB 3
- CRVO 8
- Target Price
- RRGB $12.50
- CRVO $38.75
- AVG Volume (30 Days)
- RRGB 265.6K
- CRVO 922.0K
- Earning Date
- RRGB 11-06-2024
- CRVO 11-12-2024
- Dividend Yield
- RRGB N/A
- CRVO N/A
- EPS Growth
- RRGB N/A
- CRVO N/A
- EPS
- RRGB N/A
- CRVO N/A
- Revenue
- RRGB $1,272,359,000.00
- CRVO $10,066,550.00
- Revenue This Year
- RRGB N/A
- CRVO $34.17
- Revenue Next Year
- RRGB $0.95
- CRVO N/A
- P/E Ratio
- RRGB N/A
- CRVO N/A
- Revenue Growth
- RRGB N/A
- CRVO 116.29
- 52 Week Low
- RRGB $2.97
- CRVO $1.80
- 52 Week High
- RRGB $12.80
- CRVO $26.38
- Technical
- Relative Strength Index (RSI)
- RRGB 45.53
- CRVO 24.36
- Support Level
- RRGB $5.00
- CRVO $1.81
- Resistance Level
- RRGB $5.35
- CRVO $2.10
- Average True Range (ATR)
- RRGB 0.36
- CRVO 1.59
- MACD
- RRGB -0.04
- CRVO -0.74
- Stochastic Oscillator
- RRGB 12.50
- CRVO 1.11
About RRGB Red Robin Gourmet Burgers Inc.
Red Robin Gourmet Burgers Inc is a restaurant operator. The company develops, operates, and franchises casual-dining restaurants and fast-casual restaurants in North America. Its brands are Red Robin, Red Robin Gourmet Burgers, Red Robin America's Gourmet Burgers and Spirits, Red Robin Burger Works, YUMMM, Red Robin Gourmet Burgers and Brews, and Red Robin Royalty names and logos. The company's revenue consists of sales from restaurant operations, gift card breakage, franchise royalties and fees, and other miscellaneous revenue.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.